NORTHERN DUTCHESS HOSPITAL — History
CCN 330049 | 3-year financial timeline | COVID resilience: 87/100
🛡️ Public data only — no PHI permitted on this instance.
$176M
Latest Revenue (FY2022)
+13.5%
Revenue CAGR (3yr)
4.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $137M | $160M | $176M | +10.0% | +13.5% |
| Operating Expenses | $145M | $151M | $167M | +10.6% | +7.5% |
| Operating Margin | -6.0% | 5.4% | 4.9% | -9.3% | +0.0% |
| Net Income | $-8M | $9M | $9M | -0.2% | +0.0% |
| Licensed Beds | 74 | 74 | 79 | +6.8% | +3.3% |
| Total Patient Days | 17,643 | 17,681 | 18,617 | +5.3% | +2.7% |
| Medicare Day % | 40% | 38% | 40% | +5.3% | +0.3% |
| Medicaid Day % | 4% | 3% | 4% | +23.9% | -3.1% |
COVID Impact & Recovery
Resilience Score: 87/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +28.8% ($137M → $176M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+13.5%
This Hospital
+7.6%
State Avg
Latest Margin
4.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $196M | 10.4% |
| FY2024 (proj) | $216M | 15.8% |
| FY2025 (proj) | $235M | 21.3% |